» Articles » PMID: 37601687

A Deep Learning Approach for Automatic Tumor Delineation in Stereotactic Radiotherapy for Non-small Cell Lung Cancer Using Diagnostic PET-CT and Planning CT

Overview
Journal Front Oncol
Specialty Oncology
Date 2023 Aug 21
PMID 37601687
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Accurate delineation of tumor targets is crucial for stereotactic body radiation therapy (SBRT) for non-small cell lung cancer (NSCLC). This study aims to develop a deep learning-based segmentation approach to accurately and efficiently delineate NSCLC targets using diagnostic PET-CT and SBRT planning CT (pCT).

Methods: The diagnostic PET was registered to pCT using the transform matrix from registering diagnostic CT to the pCT. We proposed a 3D-UNet-based segmentation method to segment NSCLC tumor targets on dual-modality PET-pCT images. This network contained squeeze-and-excitation and Residual blocks in each convolutional block to perform dynamic channel-wise feature recalibration. Furthermore, up-sampling paths were added to supplement low-resolution features to the model and also to compute the overall loss function. The dice similarity coefficient (), precision, recall, and the average symmetric surface distances were used to assess the performance of the proposed approach on 86 pairs of diagnostic PET and pCT images. The proposed model using dual-modality images was compared with both conventional 3D-UNet architecture and single-modality image input.

Results: The average of the proposed model with both PET and pCT images was 0.844, compared to 0.795 and 0.827, when using 3D-UNet and nnUnet. It also outperformed using either pCT or PET alone with the same network, which had of 0.823 and 0.732, respectively.

Discussion: Therefore, our proposed segmentation approach is able to outperform the current 3D-UNet network with diagnostic PET and pCT images. The integration of two image modalities helps improve segmentation accuracy.

Citing Articles

EXACT-Net: Framework for EHR-Guided Lung Tumor Auto-Segmentation for Non-Small Cell Lung Cancer Radiotherapy.

Hooshangnejad H, Huang G, Kelly K, Feng X, Luo Y, Zhang R Cancers (Basel). 2024; 16(23).

PMID: 39682283 PMC: 11639975. DOI: 10.3390/cancers16234097.


Impact of contrast-enhanced CT in the dosimetry of SBRT for liver metastases treated with MR-Linac.

Liu M, Liu M, Yang F, Liu Y, Wang S, Chen Y Radiat Oncol. 2024; 19(1):144.

PMID: 39402595 PMC: 11475857. DOI: 10.1186/s13014-024-02533-3.


Accurate and robust auto-segmentation of head and neck organ-at-risks based on a novel CNN fine-tuning workflow.

Luan S, Wu K, Wu Y, Zhu B, Wei W, Xue X J Appl Clin Med Phys. 2023; 25(1):e14248.

PMID: 38128058 PMC: 10795444. DOI: 10.1002/acm2.14248.

References
1.
Zou K, Warfield S, Bharatha A, Tempany C, Kaus M, Haker S . Statistical validation of image segmentation quality based on a spatial overlap index. Acad Radiol. 2004; 11(2):178-89. PMC: 1415224. DOI: 10.1016/s1076-6332(03)00671-8. View

2.
Wood D, Kazerooni E, Aberle D, Berman A, Brown L, Eapen G . NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022. J Natl Compr Canc Netw. 2022; 20(7):754-764. DOI: 10.6004/jnccn.2022.0036. View

3.
Zhao L, Lu Z, Jiang J, Zhou Y, Wu Y, Feng Q . Automatic Nasopharyngeal Carcinoma Segmentation Using Fully Convolutional Networks with Auxiliary Paths on Dual-Modality PET-CT Images. J Digit Imaging. 2019; 32(3):462-470. PMC: 6499852. DOI: 10.1007/s10278-018-00173-0. View

4.
Fonti R, Conson M, Del Vecchio S . PET/CT in radiation oncology. Semin Oncol. 2019; 46(3):202-209. DOI: 10.1053/j.seminoncol.2019.07.001. View

5.
Ju W, Xiang D, Xiang D, Zhang B, Wang L, Kopriva I . Random Walk and Graph Cut for Co-Segmentation of Lung Tumor on PET-CT Images. IEEE Trans Image Process. 2015; 24(12):5854-67. DOI: 10.1109/TIP.2015.2488902. View